Tau Positron Emission Tomography for Predicting Dementia in Individuals with Mild Cognitive Impairment
JAMA Neurol 81:845-856, Groot,C.,et al, 2024
Presentation, Diagnosis, Pathophysiology, and Treatment of the Neurological Features of Sturge-Weber Syndrome
The Neurologist 17:179-184, Comi, A.M., 2011
Positron Emission Tomography in Evaluation of Dementia
JAMA 286:2120-2127,2194, Silverman,D.H.S.,et al, 2001
Plasticity in the Aging Brain
Arch Neurol 47:1336-1341, Kaye,J.A.,et al, 1990
Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinsons Disease
NEJM 382:1926-1932, Schweitzer, J.S.,et al, 2020
Prevalence of Cerebral Amyloid Pathology in Persons without Dementia
JAMA 313-1924-1938,1913, Jansen, W.J.,et al, 2015
Prevalence of Amyloid PET Positivity in Dementia Syndromes
JAMA 313:1939-1949,1913, Ossenkoppele, R.,et al, 2015
PET Imaging for Alzheimer Disease: Are Its Benefits Worth the Cost?
JAMA 309:1099-1100, Mitka, M., 2013
Longitudinal Assessment of A-beta and Cognition in Aging and Alzheimer Disease
Ann Neurol 69:181-192, Villemagne,V.L.,et al, 2011
Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Eur J Neurol 18:19-27, Titulaer, M.J.,et al, 2011
Mild Cognitive Impairment
NEJM 362:2227-2234, Peterson, R.C., 2011
Pediatric Moyamoya Disease: An Analysis of 410 Consecutive Cases
Ann Neurol 68:92-101, Kim,S.-K., et al, 2010
Imaging Manifestations of Progressive Multifocal Leukoencephalopathy
Clinical Radiol 65:431-439, Shah,R.,et al, 2010
Combining MR Imaging, Positron-Emission Tomography, and CSF Biomarkers in the Diagnosis and Prognosis of Alzheimers Disease
AJNR 31:347-354, Walhovd, K.B.,et al, 2010
Acute Limbic Encephalitis and Glutamic Acid Decarboxylase Antibodies:A Reality?
J Neurosci 287:69-71, Blanc,F.,et al, 2009
Anti-Ma and Anti-Ta Associated Paraneoplastic Neurological Syndromes: 22 Newly Diagnosed Patients and Review of Previous Cases
JNNP 79:767-773,742, Hoffmann,L.A.,et al, 2008
A 60-Year-Old Woman with Mild Memory Impairment: Review of Mild Cognitive Impairment
JAMA 300:1566-1574,1598, Ellison,J.M., 2008
Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Arch Neurol 65:1509-1517, Aizenstein,H.J.,et al, 2008
Prognosis of Children With Partial Epilepsy: MRI and Serial 18FDG-Pet
Neurol 68:665-659, Gaillard,W.D.,et al, 2007
Multiple Diagnostic Tests Are Needed to Assess Multiple Causes of Dementia
Arch Neurol 63:144-146,146, Rikkert,M.G.M.O.,et al, 2006
Chronic Disorders of Consciousness
Lancet 367:1181-1192, Bernat,J.L., 2006
Long-Term Evaluation of Bilateral Fetal Nigral Transplantation in Parkinson Disease
Arch Neurol 56:179-187, Hauser,R.A.,et al, 1999
Nuclear Medicine in Neurology and Psychiatry
Lancet 354:1107-1111, Costa,D.C.,et al, 1999
Imaging the Brain, Part 1 & 2
NEJM 338:812-820, 889-8961998., Gilman,S., 1998
Clinical, Neuroimaging, and Pathologic Features of Progressive Nonfluent Aphasia
Ann Neurol 39:166-173, Turner,R.S.,et al, 1996
Clinicopath Conf
Focal Cortical Dysplasia, Case 7-1996, NEJM 334:586-592996., , 1996
Spontaneous Neurological Recovery After Stroke and the Fate of the Ischemic Penumbra
Ann Neurol 40:216-226, Furlan,M.,et al, 1996
Recovery from Wernicke's Aphasia:A Positron Emission Tomographic Study
Ann Neurol 37:723-732, Weiller,C.,et al, 1995
Neuropath Evid of Graft Survival & Striatal Reinnerva after Transpl of Fetal Mesencephalic Tissue in Parkinson's Dis
NEJM 332:1118-1124, 11631995., Kordower,J.H.,et al, 1995
Bilateral Fetal Nigral Transplantation Into the Postcommissural Putamen in Parkinson's Disease
Ann Neurol 38:379-388, Freemen,T.B.,et al, 1995
Evidence for Long-Term Survival and Function of Dopaminergic Grafts in Progressive Parkinson's Disease
Ann Neurol 35:172-180, Lindvall,O.,et al, 1994
Predictors of Outcome After Anterior Temporal Lobectomy:Positron Emission Tomography
Neurol 44:2331-2336, Mannon,E.M.,et al, 1994
Presurgical Evaluation of Temporal Lobe Epilepsy Using Temporal Spikes & Positron Emission Tomography
Arch Neurol 50:45-48, Chee,M.W.L.,et al, 1993
HIV Encephalopathy and Dementia
Psychiatr Clin North Am 15:455-466, Pajeau,A.K.&Roman,G.C., 1992
Assessment:Positron Emission Tomography
Report of Therapeutics & Technology Assessment Subcommittee of the AAN, Neurol 41:163-16791., , 1991
PET:Its Clinical Role in Neurology
JNNP 54:1-5, Brooks,D.J., 1991
Posterior Cortical Dementia with Alexia:Neurobehavioural, MRI, and PET Findings
JNNP 54:443-448, Freedman,L.,et al, 1991
National Cancer Institute Workshop Statement
Advances in Clinical Imaging Using Positron Emission Tomography, Arch Int Med 150:735-739, 729990., , 1990
Cerebral Metabolic Asymmetries & Assoc Neuro-psych Patterns in Early Dementia of the Alzheimer Type
Arch Neurol 47:753-760, Haxby,J.V., 1990
Clinical & PET Studies in the'Extrapyramidal Syndrome'of Dementia of the Alzheimer Type
Arch Neurol 47:1318-1323, Tyrrell,P.J.,et al, 1990
Normal-Pressure Hydrocephalus and the Saga of the Treatable Dementias
JAMA 262:2577-2581, 2592-25931989., Friedland,R.P., 1989
Dementia in Down's Syndrome:Cerebral Glucose Utilization, Neuropsychological Assessment, and Neuropathology
Neurol 38:938-942, Schapiro,M.B.,et al, 1988
Brain Metabolism in Mitochondrial Encephalomyopathy:A PET Study
J Comput Assist Tomogr 12:854-857, DeVolder,A.,et al, 1988
Positron Emission Tomography-A New Approach to Brain Chemistry
JAMA 260:2704-2710, Jacobson,H.G., 1988
The Lennox-Gastaut Syndrome:Metabolic Subtypes Determined by FDG Positron Emission Tomography
Ann Neurol 21:4-13, Chugani,H.T.,et al, 1987
Metabolic & Clinical Correlates of Acute Ischemic Infarction
Neurol 37:1103-1110, Kushner,M.,et al, 1987
The Metabolic Pathology of the AIDS Dementia Complex
Ann Neurol 22:700-706, Rottenberg,D.A.,et al, 1987
Comparison of PET, MRI, & CT with Pathology in a Proven Case of Alzheimer's Disease
Neurol 36:1569-1574, McGeer,P.L.,et al, 1986
Positron Computed Tomography for Studies of Myocardial & Cerebral Function
Ann Int Med 98:339-359, Phelps,M.E.,et al, 1983